RecruitingNot Applicable

Artificial Intelligence-assisted Colonoscopy With or Without Endocuff Vision

Taiwan1,000 participantsStarted 2023-05-02

Plain-language summary

Adenoma detection rate (ADR) is considered the single most important quality measure in colonoscopy and a higher ADR can reduce the risk of interval colorectal cancer (CRC). Several kinds of new endoscopes and accessories have been accessed to investigate the abilities of improving the ADR. Artificial intelligence (AI) and Endocuff vision are promising new devices to improve the ADR. However, the effect of combining AI and Endocuff vision on ADR remains unclear. The aim of this prospective randomized study is to compare the ADR of AI plus Endocuff vision, AI alone and standard colonoscopy examination.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Patients over 20 years old are undergoing outpatient sedative colonoscopy in the E-Da Hospital, E-Da cancer Hospital and Chung Shan Medical University Hospital in Taiwan Exclusion Criteria: * A prior history of of inflammatory bowel disease, colorectal cancer, previous bowel resection, Peutz-Jeghers syndrome, familial adenomatous polyposis or other polyposis syndromes * Bleeding tendency * For scheduled endoscopic treatment

What they're measuring

Adenoma detection rate

Timeframe: One month after colonoscopy

Trial details

NCT IDNCT05863208

SponsorE-DA Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

Ying Nan Tsai, MD

+88676150022 littlepig9933@gmail.com

View on ClinicalTrials.gov More Adenoma Detection Rate trials